FDA vs CE for LED Therapy Devices — What Every International Buyer Needs to Know

Having both FDA clearance and CE marking does not mean the same thing twice. It means navigating two fundamentally different regulatory systems, two different classification routes, and two different sets of evidence requirements — for the same product.

For LED therapy device buyers and specifiers sourcing from international manufacturers, one of the most common sources of confusion is the relationship between FDA clearance (United States) and CE marking (European Union). Both are forms of market authorization. Both are required or expected in their respective markets. But they are not equivalent. They do not substitute for each other. And the path to achieving one does not automatically deliver the other.

This article is written from the perspective of an LED therapy device OEM manufacturer — sharing what both regulatory pathways require, how they differ, what evidence is needed for each, and how buyers should evaluate a manufacturer’s claims about FDA status and CE compliance.

The Fundamental Difference — Premarket Review vs. Self-Declaration

The single most important distinction between FDA and CE is whether market access requires a government agency to review your technical file before you sell the product.

CE marking (EU MDR): The manufacturer compiles a technical documentation file, performs a conformity assessment (self-assessment for Class I, or notified body review for Class IIa and above), and issues a Declaration of Conformity. The notified body does not “approve” the product — it assesses whether the manufacturer’s quality system and technical file support the claims made. The manufacturer bears the legal responsibility. CE is a self-declaration model with a third-party check for higher-risk devices.

FDA (United States): For most LED therapy devices intended for therapeutic use, the manufacturer must submit a 510(k) Premarket Notification to the FDA and receive a clearance letter before the product can be marketed in the United States. The FDA reviews the technical file — specifically comparing the new device to a legally marketed predicate device — and issues a clearance decision. FDA clearance is a premarket review model. The FDA reviews what you submitted.

Both systems require a quality management system. Both require adverse event reporting. But the existence of one does not imply compliance with the other. An FDA-cleared device is not “CE compliant” by virtue of FDA clearance. A CE-marked device is not authorized for US market sale without FDA clearance.

How LED Therapy Devices Are Classified in Each System

United States — FDA Classification

The FDA classifies devices into three classes (I, II, III) based on risk and the level of regulatory control required.

Most LED therapy devices for aesthetic or wellness use fall into Class II under the 510(k) pathway. The relevant product codes:

OIF — Light Emitting Diode (LED) Lamp for Aesthetic Use (phototherapy for skin conditions, acne treatment, wrinkle reduction)
OHR — LED Phototherapy Device for Periorbital Rejuvenation

For devices with therapeutic medical claims (treatment of clinical conditions, not aesthetic claims), classification may be Class II under a different product code, or in rare cases Class III if the device is intended to be used in combination with a drug or biologic.

The predicate device route (510(k)) requires demonstrating substantial equivalence to a legally marketed predicate — the same intended use and the same technological characteristics, or the same intended use with different technological characteristics that do not raise new safety or effectiveness questions.

European Union — EU MDR Classification

Under EU MDR 2017/745 (which fully replaced the Medical Device Directive 93/42/EEC on May 26, 2021), devices are classified into Classes I, IIa, IIb, and III based on rules in Annex VIII of the regulation.

LED therapy devices are typically classified as Class IIa under Rule 9 or Rule 10, depending on the intended use and the duration of contact with the body:

Rule 9: Devices intended to administer energy in a potentially hazardous way (including thermal energy) → Class IIa for devices that deliver energy to the body in a controlled manner
Rule 10: Devices intended for diagnosis or monitoring of physiological processes, or for diagnosis of diseases in conditions that are not life-threatening → Class IIa for diagnostic or monitoring devices

For a standard LED therapy mask or panel:

If the intended use is aesthetic skin treatment (non-medical claims): Class I or Class IIa depending on whether the manufacturer makes therapeutic claims
If the intended use includes medical treatment claims: Class IIa minimum
If combined with other active components or used with a drug: Class IIb or higher

The classification is determined by the intended purpose as declared by the manufacturer in the IFU and promotional materials — and this declaration is subject to scrutiny during a notified body review.

The Technical File — What Each System Requires

FDA 510(k) Technical Summary

The 510(k) submission requires:

Device description: Full specification, materials, components, accessories, software version and functionality
Substantial equivalence discussion: Comparison to the predicate device — intended use, technological characteristics, performance data
Performance data: Bench testing (electrical safety per IEC 60601-1, electromagnetic compatibility per IEC 60601-1-2), clinical performance data if applicable, and for therapeutic devices, evidence of efficacy for the claimed indication
Biocompatibility: Per ISO 10993 series if the device has patient-contact components (silicone overmold, skin-contact surfaces)
Software documentation: Per IEC 62304 if the device includes software (driver control, intensity levels, timing)
510(k) summary: A public-facing summary of the submission, including the predicate device, indications for use, and summary of performance data

Timeline: 90 days FDA review target (although actual review times vary; 3–6 months is a realistic expectation for initial submission).

EU MDR Technical File

The EU MDR technical file is more extensive and includes:

Device description and specification: Full product description, materials, components, accessories, software specifications, variants, and accessories
Design and manufacturing information: Design specifications, manufacturing process, critical components, supply chain
General Safety and Performance Requirements (GSPR) (Annex I): 23 chapters covering safety, clinical, biocompatibility, software, labeling, and traceability requirements — each must be addressed with evidence
Benefit-risk analysis and clinical evaluation: Per ISO 14971 (risk management) and ISO 14155 or equivalent (clinical evaluation report, CER)
Post-market surveillance plan and Periodic Safety Update Report (PSUR): Required for Class IIa and above, updated at least every two years
Labeling: Per Annex I, Chapter III — including UDI carrier, EUDAMED registration, language requirements for each EU member state market
Declaration of Conformity and EU Authorized Representative: Required for all non-EU manufacturers

For Class IIa devices, a Notified Body review is required — the technical file is submitted to an EU Notified Body (an accredited third-party organization designated by an EU member state), which reviews the file and issues a CE certificate if satisfied. The manufacturer’s EU Authorized Representative holds the technical file.

Timeline: Notified Body review for Class IIa typically takes 4–9 months for initial certification, depending on the complexity of the device and the responsiveness of the manufacturer.

Electrical Safety Standards — IEC 60601-1 as Common Ground

Both FDA clearance and CE marking require compliance with IEC 60601-1 — Medical electrical equipment — Part 1: General requirements for basic safety and essential performance. This is the foundational electrical safety standard for medical and healthcare electrical devices globally.

Test	Standard	FDA Expectation	CE Expectation
General electrical safety	IEC 60601-1 + collateral standards	Required for 510(k)	Required for CE (Annex I GSPR)
EMC	IEC 60601-1-2	Required	Required
Biocompatibility	ISO 10993 series	Required (patient contact)	Required (Annex I)
Software lifecycle	IEC 62304	Required if software present	Required if software present
Usability / human factors	IEC 62366-1	Recommended	Recommended / required per interpretation

The key point for buyers: An IEC 60601-1 test report from an accredited laboratory is required for both FDA and CE. A manufacturer who claims FDA clearance but cannot produce an IEC 60601-1 test report should raise immediate red flags.

Labeling and Registration Requirements

FDA — UDI and Registration

Establishment registration: All facilities manufacturing Class I, II, or III medical devices must register annually with the FDA via the FDA Unified Registration and Listing System (FURLS)
Device listing: Each device model must be listed with the FDA
Unique Device Identifier (UDI): Required per the FDA’s UDI rule — the device must carry a UDI on the label and the UDI data must be submitted to the FDA Global Unique Device Identification Database (GUDID)
Adverse event reporting: Medical Device Reporting (MDR) per 21 CFR Part 803 — serious adverse events must be reported to the FDA within 30 days (or 5 days for immediate public health threats)

EU MDR — Labeling and EUDAMED

CE label: Must appear on the device and packaging
EU Authorized Representative: Required for all non-EU manufacturers — the AR is listed on the label and holds the technical file
EUDAMED registration: Under EUDAMED (fully operational since October 2021), devices must be registered in the European database before placing on the market
Unique Device Identification (UDI-DI/UDI-PI): Must appear on the label and uploaded to EUDAMED
Periodic Safety Update Report (PSUR): Class IIa and above — updated at least every two years, summary publicly accessible on EUDAMED
Vigilance reporting: Serious adverse incidents in EU must be reported to the relevant competent authority within 15 days (or 2 days for serious public health threats)

FDA vs CE — Key Differences at a Glance

Aspect	FDA (United States)	CE (European Union)
Legal basis	Federal Food, Drug, and Cosmetic Act	EU MDR 2017/745
Classification	Class I, II, III	Class I, IIa, IIb, III
Risk basis	Intended use + predicate device	Intended use + duration + invasiveness
Pathway	510(k) Premarket Notification (most LED devices)	Notified Body review for Class IIa+
Review by government	Yes — FDA reviews the 510(k) file	Yes — for Class IIa+ (Notified Body reviews)
Substantial equivalence	Required (510(k))	Not applicable — GSPR compliance is the standard
QMS requirement	21 CFR Part 820 (QSR) / ISO 13485	ISO 13485 (required)
Labeling	FDA labeling rules + UDI + GUDID	EU MDR Annex I + UDI + EUDAMED
Adverse event reporting	30 days / 5 days	15 days / 2 days
Timeline to clearance	3–6 months (typical)	4–9 months for Class IIa Notified Body review
Ongoing cost	Annual registration + user fees	Annual Notified Body surveillance audits + EUDAMED fees
US Agent requirement	Yes — for foreign manufacturers	EU Authorized Representative — yes, mandatory

Common Misconceptions — What Buyers Get Wrong

Misconception 1: “CE and FDA are equivalent — one covers the other.” CE and FDA are not equivalent and do not substitute for each other. CE is the EU’s market access requirement; FDA clearance is the US requirement. A device legally sold in the EU may not be legally sold in the US without FDA clearance — and vice versa. Dual market access requires dual compliance.

Misconception 2: “FDA Registered = FDA Cleared.” These are two different things. FDA Registration means the establishment (factory) is registered with the FDA and the device is listed in the FDA database — this is largely an administrative step. FDA Clearance (via 510(k)) means the FDA has reviewed the technical file and issued a clearance letter for the specific device. Only FDA Cleared devices can be marketed in the US for therapeutic claims. A manufacturer who says they are “FDA Registered” but cannot produce a 510(k) clearance letter does not have FDA market clearance.

Misconception 3: “CE is a product certification, like UL or ETL.” CE marking is not a product certification — it is a declaration of conformity made by the manufacturer. The manufacturer states that the product complies with all applicable EU directives and regulations. A Notified Body reviews the technical file for Class IIa and above, but the CE mark itself is applied by the manufacturer, not the Notified Body. Unlike UL or ETL certification (which are voluntary third-party product certifications), CE is mandatory for market access in the EU — but it is the manufacturer’s declaration, backed by the Notified Body’s review of the file.

Misconception 4: “If the device has a test report, it meets the standard.” A test report alone is not sufficient. The test report documents that a specific sample passed specific tests — it does not document that the design is sound, that the manufacturing process is consistent, or that the quality system is in place. Regulatory compliance requires the combination of: (1) valid test reports from accredited laboratories, (2) a quality management system, (3) a complete technical file, and (4) ongoing post-market surveillance. A test report without a QMS and technical file is not regulatory compliance — it is one piece of it.

FDA vs CE — Common Questions

Q1: We want to sell in both the US and EU markets. Can we use one regulatory submission to cover both?

No — FDA and CE are separate regulatory submissions, and each market has its own requirements. That said, the technical documentation for both overlaps significantly: the IEC 60601-1 test report satisfies the electrical safety requirement for both systems; the ISO 10993 biocompatibility testing satisfies both; the IEC 62304 software documentation satisfies both. A well-structured technical file designed from the start to meet both FDA and EU MDR requirements can significantly reduce the effort needed for dual submission. Work with a regulatory affairs specialist who has experience in both US and EU MDR submissions from the start — retrofitting a file designed for one market to meet the other is more expensive and more time-consuming.

Q2: What is the minimum quality management system a manufacturer needs for both FDA clearance and CE marking?

ISO 13485:2016 is the foundational quality management system standard required for CE marking under EU MDR and is effectively expected for FDA 510(k) submissions (FDA’s 21 CFR Part 820 is the US regulatory requirement, but FDA accepts ISO 13485 as a basis for demonstrating compliance). For FDA specifically, the manufacturer must be registered with the FDA and listed on the FDA registration database. For CE, the ISO 13485 certificate from a Notified Body is required, along with the Declaration of Conformity and the CE certificate for the device.

Q3: A manufacturer claims their LED therapy mask is “FDA Cleared and CE Marked.” What should we ask for to verify this?

Ask for: (1) FDA 510(k) clearance letter — the official FDA letter confirming clearance, with the 510(k) number and the cleared indications for use. Cross-reference the 510(k) number on the FDA 510(k) database (available at FDA.gov) to verify it is current and matches the device being sold. (2) CE certificate — issued by the Notified Body, with the Notified Body’s 4-digit number, the certificate number, and the scope of the certification. Verify the Notified Body and certificate number on the EU NANDO database. (3) ISO 13485 certificate — current, valid certificate from an accredited certification body. (4) Declaration of Conformity — the manufacturer’s signed declaration that the device meets all applicable EU MDR requirements. If any of these documents is missing, incomplete, or inconsistent, treat the regulatory claim as unverified until documentation is provided.

This article is written from the perspective of an LED therapy OEM manufacturer that maintains both FDA 510(k) clearance and CE marking under EU MDR for its product range. Regulatory pathways, classification rules, and documentation requirements reflect current FDA and EU MDR regulations as of 2024. Regulatory requirements are subject to change — always verify current requirements with a qualified regulatory affairs specialist for your specific device and target markets.